Metro Health Hospital
Grand Rapids, Michigan 49519
0 studies enrolling now · 22 studies all time
What they study most
Breast Cancer, Coronary Vessel Occlusion, Esophageal Cancer, Fallopian Tube Cancer, Gastric Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Melanoma (Skin), Multiple Myeloma, Ovarian Cancer, Prostate Cancer
Studies at this site
- Study of the CAT RX Aspiration Catheter When Used in Patients With Large Occlusive Thrombus in Coronary Arteries — Completed
- Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia — Stopped early
- S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer — Completed
- Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer — Completed
- Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole — Completed
- S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer — Completed
- Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer — Completed
- S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma — Stopped early
- S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer — Completed
- S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma — Completed
- Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer — Completed
- S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer — Stopped early
- S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer — Completed
- S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma — Completed
- S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas — Completed
- S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors — Completed
- S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction — Completed
- S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy — Completed
- S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer — Completed
- S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery — Completed
- S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery — Stopped early
- Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass — Status unconfirmed